Global Preeclampsia Diagnostics Market Growth 2023-2029

Global Preeclampsia Diagnostics Market Growth 2023-2029

The global Preeclampsia Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Preeclampsia Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Preeclampsia Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Preeclampsia Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Preeclampsia Diagnostics players cover Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health, Danaher Corporation, Diabetomics, Inc., DIRUI Industrial Co., Ltd. and F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Preeclampsia is a specific complication of pregnancy. A systolic blood pressure of at least 140 mmHg or a diastolic blood pressure of at least 90 mmHg during pregnancy, and protein in the urine (proteinuria), both present after 20 weeks of pregnancy, is diagnostic. If only new-onset hypertension, It is called gestational hypertension (without proteinuria or other signs of organ infection). Before the 20th week of pregnancy, some women develop high blood pressure, which is called chronic hypertension. Preeclampsia and chronic hypertension are common hypertensive problems during pregnancy. Preeclampsia usually presents in the third trimester with few symptoms.

LPI (LP Information)' newest research report, the “Preeclampsia Diagnostics Industry Forecast” looks at past sales and reviews total world Preeclampsia Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Preeclampsia Diagnostics sales for 2023 through 2029. With Preeclampsia Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preeclampsia Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Preeclampsia Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preeclampsia Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Preeclampsia Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preeclampsia Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preeclampsia Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Preeclampsia Diagnostics market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Reagent
Instrument

Segmentation by application
Hospital
Medical Center
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
ACON Laboratories, Inc.
ARKRAY, Inc.
Bio-Rad Laboratories, Inc.
Cardinal Health
Danaher Corporation
Diabetomics, Inc.
DIRUI Industrial Co., Ltd.
F. Hoffmann-La Roche Ltd.
Metabolomic Diagnostics Ltd.
Sera Prognostics
Siemens Healthineers AG
Other prominent players

Key Questions Addressed in this Report

What is the 10-year outlook for the global Preeclampsia Diagnostics market?

What factors are driving Preeclampsia Diagnostics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Preeclampsia Diagnostics market opportunities vary by end market size?

How does Preeclampsia Diagnostics break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.